Myomo, Inc. Restricted Cash Equivalents
Myomo, Inc. (MYO) had Restricted Cash Equivalents of $11.22 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashEquivalents · last filed 2026-08-05
- 2026-06-30: Restricted Cash Equivalents $11.22M.
- 2026-03-31: Restricted Cash Equivalents $11.40M.
- 2025-12-31: Restricted Cash Equivalents $14.13M.
- 2025-03-31: Restricted Cash Equivalents $19.79M.
| Period end | Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $11.22M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $11.40M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $14.13M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $19.79M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $24.37M 10-K · filed 2026-03-09 |
| 2023-12-31 | $6.87M 10-K · filed 2025-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B |